According to The Independent, sales of Pfizer, Inc.’s erectile dysfunction (ED) drug Viagra rose 47 percent last year in China. The spike in regional profits comes at a time when Viagra’s global sales are falling due to patent loss and competition from other pharmaceutical giants, like Eli Lilly & Co.
Viagra has been linked in studies to an increased risk of melanoma, a dangerous type of ...
continue reading...